Indeed, myeloid-specific deletion of cholesterol efflux genes ABCA1 and ABCG1 or inhibition of IL-4R signaling, STAT6, or PI3K has been found to significantly impair tumor progression in an ovarian cancer model [309]. Here, IL4R is linked to neoplasm.